A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.

ABSTRACT:

SUBMITTER: Goldstein JA 

PROVIDER: S-EPMC2662477 | biostudies-literature | 2009 Mar-Apr

REPOSITORIES: biostudies-literature